Javascript must be enabled to continue!
Rat parathyroid allotransplantation: Influence of MHC antigen expression on graft survival
View through CrossRef
AbstractMHC antigen expression in parathyroid tissue and its influence on graft survival after allogeneic transplantation were investigated using a heterotopic rat transplantation model. MHC class I and II expression in parathyroid tissue of Lewis (LEW), Dark Agouti (DA), and Wistar‐Furth (WF) rats was analysed semi‐quantitatively by using immunohistochemistry. MHC class I expression was strong in DA, moderate in WF, and weak in LEW rats parenchyma, whereas MHC class II expression was negative. In the interstitium of all investigated tissue specimens, the proportion of MHC class II–expressing cells was low. Additionally, four groups were transplanted: 1) LEW to LEW, 2) DA to DA, 3) LEW to DA, and 4) WF to LEW. After syngeneic transplantation, graft survival could be documented over the whole observation period. A median graft survival of 20 (±2) days was observed after transplantation from LEW to DA, whereas grafts in the group WF to LEW were rejected after 13 (±1) days. The number of intra‐graft leucocytes expressing MHC class II molecules was the same in all groups, whereas increased levels of MHC class I in parathyroid tissue before transplantation resulted in a more rapid rejection. These results indicate that immunogenicity of rat parathyroid tissue might be determined by the amount of MHC class I expressed in donor parenchymal cells. Further experiments are necessary to validate this observation. © 2001 Wiley‐Liss, Inc. Microsurgery 21:221–222 2001
Title: Rat parathyroid allotransplantation: Influence of MHC antigen expression on graft survival
Description:
AbstractMHC antigen expression in parathyroid tissue and its influence on graft survival after allogeneic transplantation were investigated using a heterotopic rat transplantation model.
MHC class I and II expression in parathyroid tissue of Lewis (LEW), Dark Agouti (DA), and Wistar‐Furth (WF) rats was analysed semi‐quantitatively by using immunohistochemistry.
MHC class I expression was strong in DA, moderate in WF, and weak in LEW rats parenchyma, whereas MHC class II expression was negative.
In the interstitium of all investigated tissue specimens, the proportion of MHC class II–expressing cells was low.
Additionally, four groups were transplanted: 1) LEW to LEW, 2) DA to DA, 3) LEW to DA, and 4) WF to LEW.
After syngeneic transplantation, graft survival could be documented over the whole observation period.
A median graft survival of 20 (±2) days was observed after transplantation from LEW to DA, whereas grafts in the group WF to LEW were rejected after 13 (±1) days.
The number of intra‐graft leucocytes expressing MHC class II molecules was the same in all groups, whereas increased levels of MHC class I in parathyroid tissue before transplantation resulted in a more rapid rejection.
These results indicate that immunogenicity of rat parathyroid tissue might be determined by the amount of MHC class I expressed in donor parenchymal cells.
Further experiments are necessary to validate this observation.
© 2001 Wiley‐Liss, Inc.
Microsurgery 21:221–222 2001.
Related Results
Abstract PS12-04: HDACi combined with anthracycline elicits interactions between MHC-II+ triple-negative breast cancer and CD69+CD4+Trm orchestrating synergistic immunotherapy
Abstract PS12-04: HDACi combined with anthracycline elicits interactions between MHC-II+ triple-negative breast cancer and CD69+CD4+Trm orchestrating synergistic immunotherapy
Abstract
Background: Early TNBC (eTNBC) lacks biomarkers for predicting the benefits of immune checkpoint blockade (ICB). Therefore, identifying indicators for the h...
Primary and Metastatic Parathyroid Malignancies: A Rare or Underdiagnosed Condition?
Primary and Metastatic Parathyroid Malignancies: A Rare or Underdiagnosed Condition?
Objective:
Parathyroid gland malignancies are considered rare. The most common of these tumor types is primary parathyroid carcinoma. Metastatic spread from other...
Abstract 1370: Targeting LSD1 rescues MHC-I antigen presentation in small cell lung cancer
Abstract 1370: Targeting LSD1 rescues MHC-I antigen presentation in small cell lung cancer
Abstract
Purpose: Small cell lung cancer (SCLC) is a highly aggressive cancer with early primary resistance and modest clinical benefit to immune checkpoint blockade...
Abstract 2687: Immunopotentiator, protein-bound polysaccharide K, is efficient for advanced gastric cancer with negative expression of MHC Class I
Abstract 2687: Immunopotentiator, protein-bound polysaccharide K, is efficient for advanced gastric cancer with negative expression of MHC Class I
Abstract
It has been reported that down-regulation of MHC class I in cancer cells was associated with poor prognosis of gastrointestinal cancer, because of immunolog...
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
1.Effect of chronic haloperidol treatment on D‐2 receptors labelled by (3H)‐spiperone in homogenates of rat corpus striatum. A. L. Gundlach, D. J. de Vries and P. M. Beart2.The eff...
Recipient bone marrow‐derived stromal cells prolong graft survival in a rat hind limb allotransplantation model
Recipient bone marrow‐derived stromal cells prolong graft survival in a rat hind limb allotransplantation model
BackgroundRecent studies have indicated that bone marrow‐derived stromal cells (BMSCs) have immunomodulatory properties that suppress the T cell responses that cause graft rejectio...
Left parathyroid carcinoma with secondary hyperparathyroidism: a case report
Left parathyroid carcinoma with secondary hyperparathyroidism: a case report
Abstract
Background: Parathyroid carcinoma is a rare disease with a frequency of 0.005% of all malignancies [1,2]. Furthermore, cases with secondary hyperparathyroidism are...
Pseudohypoparathyroidism versus signaling disorder: A case report
Pseudohypoparathyroidism versus signaling disorder: A case report
Pseudohypoparathyroidism is a terminology used to describe a group of metabolic disorders characterized by parathyroid hormone resistance. Patients with pseudohypoparathyroidism ha...

